1. Home
  2. EUDA vs LSTA Comparison

EUDA vs LSTA Comparison

Compare EUDA & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EUDA Health Holdings Limited

EUDA

EUDA Health Holdings Limited

HOLD

Current Price

$14.49

Market Cap

31.0M

Sector

Finance

ML Signal

HOLD

Logo Lisata Therapeutics Inc.

LSTA

Lisata Therapeutics Inc.

HOLD

Current Price

$1.13

Market Cap

28.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EUDA
LSTA
Founded
2021
1980
Country
Singapore
United States
Employees
N/A
N/A
Industry
Blank Checks
Misc Health and Biotechnology Services
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.0M
28.9M
IPO Year
2021
2000

Fundamental Metrics

Financial Performance
Metric
EUDA
LSTA
Price
$14.49
$1.13
Analyst Decision
Strong Buy
Buy
Analyst Count
1
2
Target Price
$55.00
$15.00
AVG Volume (30 Days)
3.6K
113.0K
Earning Date
12-19-2023
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
20.42
EPS
N/A
N/A
Revenue
N/A
$35,283,868.00
Revenue This Year
$134.73
N/A
Revenue Next Year
$195.03
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
56.90
52 Week Low
$0.33
$0.99
52 Week High
$25.70
$5.07

Technical Indicators

Market Signals
Indicator
EUDA
LSTA
Relative Strength Index (RSI) 46.33 27.17
Support Level $0.68 $0.99
Resistance Level $15.36 $1.28
Average True Range (ATR) 0.86 0.11
MACD -0.43 0.07
Stochastic Oscillator 15.52 38.54

Price Performance

Historical Comparison
EUDA
LSTA

About EUDA EUDA Health Holdings Limited

EUDA Health Holdings Ltd is a Singapore-based non-invasive healthcare provider in Asia with a focus on Singapore, Malaysia, and China. It offers inventive, accessible, and science-based health solutions to support the shift in regional healthcare from reactive medical treatment to proactive, longevity-focused care. The group also runs a Singapore-based property management business. It operates in two reportable segments: property management services and holistic wellness consumer products and services. Key revenue is generated from property management services that include management and security services for properties such as condominiums, residential apartments, business office buildings, and shopping malls.

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.

Share on Social Networks: